Can Rhetorical Momentum Influence Agreement in Science?

We have all witnessed the rhetorical impact of language in popular culture. Certain terms may serve ideological goals but mislead us about the reality they signify. How about scientific language? Does a particular terminology help shape agreement even when it is misleading or seems theoretically neutral? Let's take one example: the prion. Stanley Prusiner, who was awarded the Nobel Prize in physiology or medicine in 1997, coined the term prion when he proposed in 1982 that the cause of scrapi

Written byCarol Reeves
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

We have all witnessed the rhetorical impact of language in popular culture. Certain terms may serve ideological goals but mislead us about the reality they signify. How about scientific language? Does a particular terminology help shape agreement even when it is misleading or seems theoretically neutral? Let's take one example: the prion.

Stanley Prusiner, who was awarded the Nobel Prize in physiology or medicine in 1997, coined the term prion when he proposed in 1982 that the cause of scrapie, a neurodegenerative disease in sheep, is a protein particle that somehow replicated without nucleic acid. In that first article, the prion, or "proteinacious infectious particle,"1 represented a provocative idea that was, Prusiner conceded, heretical. He admitted that "skepticism ... is certainly justified. Only purification of the scrapie agent to homogeneity and determination of its chemical structure will allow a rigorous conclusion."

Prusiner's baptism of the new term began a new ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies